Journals / Respiratory Case Reports / 2020 / Cilt: 9 - Sayı: 2

The 2019 Novel Coronavirus Disease (COVID-19) causing Severe ARDS: Serial Computed Tomography Findings

Yeni Corona Virüs Hastalığı (COVİD-19) Ağır ARDS' ye Neden Oluyor: Bilgisayarlı Tomografi Bulguları Serisi

Pages
38–42
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additional clinical data are required to determine whether or not corticosteroid use is clinically beneficial.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Since mid-December 2019, a novel coronavirus (COVID-19) has spread to many countries around the world, and the number of critically ill patients with COVID-19 is increasing as the number infections increase.
📊
Key Findings & Data:Here, we present the clinical course and serial computed tomography of a critically ill Korean patient with COVID-19.
💡
Conclusion & Impact:Additional clinical data are required to determine whether or not corticosteroid use is clinically beneficial.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Since mid-December 2019, a novel coronavirus (COVID-19) has spread to many countries around the world, and the number of critically ill patients with COVID-19 is increasing as the number infections increase. The optimum treatment and prognosis of the disease is still unknown. Here, we present the clinical course and serial computed tomography of a critically ill Korean patient with COVID-19. The progression of COVID-19 infection is fast and aggressive, and no treatment protocol has yet been established. Additional clinical data are required to determine whether or not corticosteroid use is clinically beneficial.

Özet

Yeni korona virüs (Covid-19) 2019 Aralık ortalarından beri dünyada pek çok ülkede yayılmakta veCOVID-19'lu ağır hasta sayısı, enfeksiyon sayısı arttıkça artmaktadır. Hastalığın optimum tedavisi veprognozu halen bilinmemektedir. Burada, COVİD 19’lu Kore’li bir ağır hastanın klinik seyri ve seri bilgisayarlı tomografi bulgularını sunduk. COVİD-19enfeksiyonunun progresyonu hızlı ve agresif oluphenüz tedavi protokolü oluşturulmamıştır. Kortikosteroid kullanımının klinik yararı olup olmadığını belirlemek için ilave klinik verilere ihtiyaç vardır

🔖

Cite This Article

KIM, J., LEE, J., JIN, S. (2022). The 2019 Novel Coronavirus Disease (COVID-19) causing Severe ARDS: Serial Computed Tomography Findings. Respiratory Case Reports, Cilt: 9 - Sayı: 2, 38–42. https://ajindex.com/articles/588944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-nCoV and Naming it SARS-CoV-2. Nat Microbiol 2020; 5;536–44. [CrossRef] 2. World Health Organization. Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases: access date: 19 March 2020. Place of access: https://www.who.int. 3. Guidlines for the Laboratory Diagnosis of 2019 Novel Coronavirus(2019-nCoV) in Korea. 1 ed: Central for Disease Control; 2020. [CrossRef] 4. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; pii: S2213-2600(20)30079-5. [CrossRef] 5. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020; 87:281-6. [CrossRef] 6. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures. J Korean Med Sci 2020; 35:e61. [CrossRef] 7. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177–9. [CrossRef] 8. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020; 382:1787-99. [CrossRef] 9. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395:473-5. [CrossRef]